Novadaq Reports Financial Results for the First Quart... (26823068 ...)

HOME >> MEDICINE >> NEWS

Novadaq Reports Financial Results for the First Quarter of 2008

Date:5/12/2008

26,823,068

--------------------------

Long-term investments 426,000 426,000

Long-term receivable 52,312 -

Property, plant and equipment, net 2,942,731 2,785,342

Prepaid expenses 340,290 323,761

Deferred development costs 331,183 331,183

Intangible assets 10,722,513 11,030,760

--------------------------

34,714,219 41,720,114

--------------------------

LIABILITIES AND SHAREHOLDERS' EQUITY

Current

Accounts payable and accrued liabilities 3,991,841 6,289,722

Current portion of deferred revenue 908,729 995,099

--------------------------

Total current liabilities 4,900,570 7,284,821

--------------------------

Deferred revenue 461,145 446,118

--------------------------

Total liabilities 5,361,715 7,730,939

--------------------------

Shareholders' equity

Share capital 80,134,644 80,109,644

Contributed surplus 4,462,448 4,285,187

Accumulated other comprehensive loss (69,000) (69,000)

Deficit (55,175,588) (50,336,65
'/>"/>

SOURCE Novadaq Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11
Related medicine news :

1. Novadaq Resumes Normal Business Operations by Securing ICG for SPY
2. Novadaq launches PINPOINT: Companys first minimally invasive imaging system
3. Novadaq announces third quarter 2007 conference call and webcast
4. Novadaq to present at Piper Jaffray Healthcare Conference
5. Novadaq to present at BMO Healthcare Conference
6. Novadaqs SPY Imaging System named Product of the Year by Frost and Sullivan
7. Novadaqs SPY System receives clearance for use in organ transplant surgery
8. Novadaq Data Presented at 2008 Society of Thoracic Surgeons Meeting
9. NOVADAQs SPY System to be Featured During Live Broadcast of Robotic Surgery
10. Novadaq to present at Cowen Healthcare Conference
11. Novadaq to hold fiscal 2007 year-end and fourth quarter results conference call and webcast

Post Your Comments:

(Date:1/8/2009)... the surface of cancer cells are keys to the devel... stopping the spread of certain types of cancers c...ovarian and lung, among others. Armed with a new ...ancer Research, an Illinois-based philanthropic fo....D., and her co-workers at the Moores Cancer Cente...

(Date:1/8/2009)...rtful comments, study suggests , , THUR...stimate how strongly they would react to racist ac...ercent of study participants at York University, i...t with a white person rather than a black one, eve...t the black person when he left the room. , "...

(Date:1/8/2009)...wire-FirstCall/ -- Allscripts-Misys Healthcare,So...tions, Inc. (Allscripts or,the Company), today an...x,months ended November 30, 2008. , (Logo:...SCRIPTSLOGO-b ) , The Company,s results for...,include results from legacy Allscripts for the pe...

(Date:1/8/2009)...ewswire-USNewswire/ -- A new educational Web site ... drugs, biological products and medical devices fr...s Centers for Education and Research on Therapeuti...than a dozen leading research centers nationwide. ...n Network ( CHAIN ) http://www.chainonline.org l...

[0] Novel prostate cancer vaccine taking aim at cancer cell 'sweet spot'[0] Many Turn Blind Eye to Racism [0] Allscripts Reports Fiscal 2009 Second Quarter Results [0] AHRQ Announces New Web Site on Emerging Issues in Medical Therapeutics

...from the lungs of transplant patients demonstrates...reside in adult organs and are not derived from bo... cells may be able to help with the rejection of d...f lung disease. The study by University of Michig...

...r patients undergoing chemotherapy and radiation t...e. //The study is also trying to investigate what ...n a healthy diet during treatment. Researchers at...e effects of chemotherapy and radiation therapy on...

...to produce a compound that regulates immune respon...or beating food allergies, if results from an anim...stophe Frossard and Philippe Eigenmann from the Un...oration with Lothar Steidler from University Colle...

...ts of Canada’s conjoined twins and to the public, ...nfirmed //after days of several tests that the twi...ins, known by the names Krista and Tatiana Hogan c...ined. The twins, who are four months of age, portr...

Other Medicine News:Health News:Stem Cell Finding Could Help Reduce Transplant Rejection 2 Health News:Stem Cell Finding Could Help Reduce Transplant Rejection 3 Health News:Special Diets Necessary for Those Undergoing Chemotherapy 2 Health News:Lactococcus Strain may Offer End to Food Allergies 2

Stem Cell Finding Could Help Reduce Transplant Rejection Special Diets Necessary for Those Undergoing Chemotherapy Lactococcus Strain may Offer End to Food Allergies Canada’s Conjoined Twins Growing Normall

(Date:1/7/2009)...ANAPOLIS, Jan. 7 Eli Lil...t it received a complete response letter from,the...apine long-acting,injection (LAI) for acute and m...Lilly is continuing to work with the agency on the...s not require any additional clinical trials for t...

(Date:1/7/2009)...K, Md., Jan. 7 ImQuest Life Scienc... IND application to the Food and Drug Administrati...d pyrimidinedione HIV inhibitor IQP-0410. ImQuest ...e first quarter of 2009. IQP-0410 is a novel small... a nonnucleoside reverse transcriptase inhibitor (...

(Date:1/7/2009)...RD, England, January 7 Circassia L... on allergy and critical care, today,announced th...in 2008 with,its ToleroMune(R) anti-allergy techn...uitment for a further phase II clinical trial in c...a, has recruited 120 patients with confirmed,cat ...

(Date:1/6/2009)... N.Y., Jan. 6 In recent controlled...sity of Memphis , scientists found that the patent...he first and only proven ingredient to increase le...reasing blood nitrate/nitrate (NOx) in human subje... enables an increase in blood flow to the skeletal...

Breaking Medicine Technology:FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 2 FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 3 FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 4 FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 5 FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 6 ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2 Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2 Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3 US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2 Helping Veterans in Our Communities 26117 1 Helping Veterans in Our Communities 26117 2 Helping Veterans in Our Communities 26117 3 Valley Baptist Health System Selects Concuitys ClearContracts to More Accurately Calculate Payments from Managed Care and Government Payers 7524 1 Valley Baptist Health System Selects Concuitys ClearContracts to More Accurately Calculate Payments from Managed Care and Government Payers 7524 2 Valley Baptist Health System Selects Concuitys ClearContracts to More Accurately Calculate Payments from Managed Care and Government Payers 7524 3 Valley Baptist Health System Selects Concuitys ClearContracts to More Accurately Calculate Payments from Managed Care and Government Payers 7524 4 Healthy individuals may be at risk for heart disease 26112 1 Healthy individuals may be at risk for heart disease 26112 2 Big Tobaccos Grip on Colleges and Students Loosens But Still Holding Strong 3A New Report Examines Trends on Campuses 26110 1 Big Tobaccos Grip on Colleges and Students Loosens But Still Holding Strong 3A New Report Examines Trends on Campuses 26110 2 Big Tobaccos Grip on Colleges and Students Loosens But Still Holding Strong 3A New Report Examines Trends on Campuses 26110 3 Big Tobaccos Grip on Colleges and Students Loosens But Still Holding Strong 3A New Report Examines Trends on Campuses 26110 4

[2] FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults [0] ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 [0] Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment [0] US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream

...rmacokinetics and Dose Proportionality of,Company,...ceutics,Journal -, LAVAL, QC, June 29, 2007 /PRNew...that it will present a poster discussing the dose,...l at the 3rd,International Forum on Pain Medicine ...nada. , The poster compares two different titratio...

... Development Program for Oral Compounds,to Treat ...WIRE)--July 2, 2007--Alkermes, Inc.,(Nasdaq: ALKS)... a,clinical trial of ALKS 29 in alcohol dependent ...s to move forward with its,development program for...ce. ALKS 29 is a combination of two agents with di...

Other Medicine Technology:Labopharm to Present Poster on Dose Titration of Once-daily,Tramadol at 3rd International Forum on Pain Medicine 2 Labopharm to Present Poster on Dose Titration of Once-daily,Tramadol at 3rd International Forum on Pain Medicine 3 Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 2 Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 3 Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 4

Labopharm to Present Poster on Dose Titration of Once-daily,Tramadol at 3rd International Forum on Pain Medicine Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29

5x6mm Loop, 2 Irrigation Ports at 10, 2 O'Clock, 18 Gauge Thin Walled 1.2mm Shaft; overall length 40mm; stainless steel

A long, thick-walled cannula which contains a coaxial 12 Fr cannula pre-loaded with a Dotter Helical Loop Basket and a Tip Deflecting Wire Guide. The pre-loaded cannula passes through the outer cannu

...gery is a non-invasive, virtually pain-free altern... radiotherapy for selected indications. With Lekse...ng and patient positioning improves the ability to...arget. This allows a more selective irradiation an...

Clinac Platinum Plus accelerators offer all the high performance features of the EX series and come with the latest high-precision dose sculpting technology for advanced tumor control.

Medicine Products:

Infusion Lens Loop Byrd Workstation Femoral Intravascular Retrieval Set Gamma Knife Platinum Plus

Novadaq Reports Financial Results for the First Quart...(26823068 ...),Health